Virica Biotech is Building an Ecosystem to Ramp Up AAV Production portfolioDynamk CapitalOctober 30, 2024
Lucid Scientific Highlighted by Memorial Sloan Kettering Cancer Center in The Scientist portfolioDynamk CapitalOctober 16, 2024
Alpenglow Biosciences to receive up to $21M through ARPA-H as part of the Cancer Moonshot initiative portfolioRichard FerraroAugust 19, 2024
Virica Biotech Selected as a Lead Project as Part of NIIMBL's $10M Biomanufacturing Projects portfolioDynamk CapitalApril 11, 2024
Bit.bio makes two big announcements in Alzheimer’s and Parkinson’s research and collaboration portfolioDynamk CapitalMarch 5, 2024
Curibio Leverages Their 3D Neuromuscular Junction Model for Botox Potency Assay in Collaboration with Genetox and DreamCIS portfolioDynamk CapitalFebruary 26, 2024
Portfolio company RoosterBio Announce Collaboration with Waisman Biomanufacturing For GMP Manufacturing of Cell & Exosome Therapies portfolioDynamk CapitalFebruary 7, 2024
bit.bio announces cell therapy pipeline and expanded Scientific Advisory Board portfolioDynamk CapitalNovember 13, 2023
Virica Biotech Receives Grant through Ontario Genomics’ BioCreate accelerator portfolioDynamk CapitalNovember 8, 2023
Cytiva & RoosterBio Collaborate to Address Exosome Manufacturing Challenges portfolioDynamk CapitalOctober 25, 2023
Portfolio Company Vectron Biosolutions and Cytovance Biologics Partner to Improve Development of Biologics portfolioDynamk CapitalOctober 11, 2023
Portfolio company CellFE Biotech has closed their Series A funding round, securing $22 million in financing Dynamk CapitalSeptember 27, 2023
Curi Bio Launches Nautilus™ and Stingray™ Platforms for Advancing Translational Research portfolioDynamk CapitalSeptember 20, 2023
bit.bio and BlueRock Therapeutics announce collaboration to advance T cell (Treg) based therapies portfolioDynamk CapitalAugust 3, 2023
Alpenglow awarded $1.6M grant to develop AI-enabled smart microscopy and 3D cancer database Dynamk CapitalAugust 2, 2023
Alpenglow Biosciences CEO, Nick Reder Featured in Recent Pharma's Almanac Interview Dynamk CapitalJuly 17, 2023
Vernal Biosciences Announces an Additional $20MM in Funding to Expand GMP mRNA and LNP Manufacturing portfolioDynamk CapitalJune 29, 2023
Virica Biotch To Expand Domestic Vaccine Manufacturing Capacity with Government Support portfolioDynamk CapitalApril 24, 2023
